Literature DB >> 23725876

Novel oral anticoagulants in gastroenterology practice.

Jay Desai1, Christopher B Granger, Jeffrey I Weitz, James Aisenberg.   

Abstract

Keywords:  AF; ARISTOTLE; ASGE; American Society for Gastrointestinal Endoscopy; INR; NOAC; NSAID; PCC; PPI; PT; RE-LY; ROCKET-AF; RR; aPTT; activated partial thromboplastin time; apixaban for reduction in stroke and thromboembolic events in atrial fibrillation; atrial fibrillation; international normalized ratio; nonsteroidal anti-inflammatory drug; novel oral anticoagulant; prothrombin complex concentrate; prothrombin time; proton pump inhibitor; randomized evaluation of long term anticoagulant therapy; relative risk; rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation

Mesh：

Substances：

Year:  2013        PMID： 23725876     DOI： 10.1016/j.gie.2013.04.179

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN： 0016-5107            Impact factor:   9.427


× No keyword cloud information.
  19 in total

1.  Gastrointestinal endoscopy in patients taking novel oral anticoagulants.

Authors:  James Aisenberg
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

2.  A prospective, multicenter survey on the validity of shorter periendoscopic cessation of antithrombotic agents in Japan.

Authors:  Katsuhiro Mabe; Mototsugu Kato; Koji Oba; Soichi Nakagawa; Hideyuki Seki; Shinichi Katsuki; Kentaro Yamashita; Shoko Ono; Yuichi Shimizu; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2016-04-16       Impact factor: 7.527

3.  Clinical Discussions in Antithrombotic Therapy Management : A Delphi Consensus Panel.

Authors:  Gabriello Marchetti; Emanuele Bertaglia; Alberto Camerini; Giuseppe De Angelis; Lucia Filippucci; Antonio Maggi; Sebastiano Marra; Carlo Racani; Carlo Serrati
Journal:  J Atr Fibrillation       Date:  2020-02-28

Review 4.  Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).

Authors:  Hakeam A Hakeam; Nasser Al-Sanea
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

Review 5.  Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice.

Authors:  Nicola Ferri; Elisa Colombo; Marco Tenconi; Ludovico Baldessin; Alberto Corsini
Journal:  Pharmaceutics       Date:  2022-05-24       Impact factor: 6.525

6.  Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants.

Authors:  Naohiro Yanagisawa; Naoyoshi Nagata; Kazuhiro Watanabe; Tatsuhiro Iida; Mariko Hamada; Sakurako Kobayashi; Takuro Shimbo; Junichi Akiyama; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

Review 7.  Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Authors:  Ka-Shing Cheung; Wai K Leung
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

8.  Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants.

Authors:  Kyohei Maruyama; Takatsugu Yamamoto; Hitoshi Aoyagi; Akari Isono; Koichiro Abe; Shinya Kodashima; Hiroto Kita; Yuji Watari; Ken Kozuma
Journal:  Biomed Res Int       Date:  2018-05-15       Impact factor: 3.411

Review 9.  Highlights from the 52nd Seminar of the Korean Society of Gastrointestinal Endoscopy.

Authors:  Eun Young Kim; Il Ju Choi; Kwang An Kwon; Ji Kon Ryu; Ki Baik Hahm
Journal:  Clin Endosc       Date:  2015-07-24

Review 10.  Management of bleeding in patients treated with direct oral anticoagulants.

Authors:  Marcel Levi
Journal:  Crit Care       Date:  2016-08-20       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.